Needham Reiterates Buy on Vaxcyte, Maintains $95 Price Target
Vaxcyte -0.12% Pre
Vaxcyte PCVX | 112.80 112.80 | -0.12% 0.00% Pre |
Needham analyst Joseph Stringer reiterates Vaxcyte (NASDAQ:
PCVX) with a Buy and maintains $95 price target.
Needham Reiterates Buy on Vaxcyte, Maintains $95 Price Target
Vaxcyte PCVX | 112.80 112.80 | -0.12% 0.00% Pre |